Még nem toboroz
Adebrelimab Combined With Chemoradiotherapy in Patients With Large Bulky Stage III Unresectable Non-Small Cell Lung Cancer
NCT07560358· 3. fázis· Cancer Institute and Hospital, Chinese Academy of Medical Sciences· Forrás
Contact: Zhijie Wang, MD
Toboroz
A Retrospective Real-World Study Based on RATIONALE-307
NCT07478809· Cancer Institute and Hospital, Chinese Academy of Medical Sciences· Forrás
Contact: Wang Zhijie
Toboroz
177Lu-CTR-FAPI for the Treatment of Thyroid Cancer
NCT07438847· 1. fázis· SHAOYAN LIU· Forrás
Contact: Ziren Kong, M.D.
Meghívásos bevonás
Retrospective Multicenter Study of Patient-level T1CE/FLAIR MRI Deep Learning to Predict EGFR/ALK Driver Status in NSCLC Brain Metastases With External Validation and Survival Analysis
NCT07373951· Ming Yang· Forrás
Toboroz
CONNEctome-guided Navigation for Eloquent-area Tumor Surgery Trial
NCT07657403· Cancer Institute and Hospital, Chinese Academy of Medical Sciences· Forrás
Contact: Ming Yang, M.D.
Toboroz
CTR-FAPI-guided Precision Surgery for Newly Diagnosed MTC
NCT07383246· 3. fázis· Cancer Institute and Hospital, Chinese Academy of Medical Sciences· Forrás
Contact: Ziren Kong, MD
Toboroz
Consolidation Radiotherapy vs. Observation in Oligoresidual Advanced Non-Small Cell Lung Cancer After Chemo-Immunotherapy
NCT07014202· 2. fázis· Cancer Institute and Hospital, Chinese Academy of Medical Sciences· Forrás
Contact: Zhijie, MD
Toboroz
A Clinical Prediction Model for Surgical Site Infection After Central Nervous System Tumor Surgery
NCT07378683· Ming Yang· Forrás
Contact: Ming Yang, MD
Toboroz
A Multi-omics Sequencing-based Model for Predicting Efficacy and Dynamic Monitoring of Treatment in Small Cell Lung Cancer
NCT07026669· Cancer Institute and Hospital, Chinese Academy of Medical Sciences· Forrás
Contact: Zhijie Wang, MD
Toboroz
Multiple Omics Sequencing Technologies in Predicting the Efficacy and Monitoring the Recurrence of Non-Small Cell Lung Cancer
NCT07057102· Cancer Institute and Hospital, Chinese Academy of Medical Sciences· Forrás
Contact: Zhijie Wang, MD
Toboroz
68Ga-TCR-FAPI PET/CT Guided Precision Surgery for MTC
NCT06277180· Cancer Institute and Hospital, Chinese Academy of Medical Sciences· Forrás
Contact: Shaoyan Liu, M.D.
Toboroz
Chidamide/Everolimus for PIK3CA Wild-type/Mutant HR+/HER2- Advanced Breast Cancer
NCT05983107· 2. fázis· Cancer Institute and Hospital, Chinese Academy of Medical Sciences· Forrás
Contact: Fei Ma
Még nem toboroz
YK-029A as First-Line Treatment Versus Platinum-Based Chemotherapy for Non-Small Cell Lung Cancer (NSCLC) With EGFR Exon 20 Insertion Mutations
NCT05767892· 3. fázis· Suzhou Puhe Pharmaceutical Technology Co., LTD· Forrás
Contact: Jie Wang, Doctor
Toboroz
Nimotuzumab Concurrent With Chemoradiotherapy for Patients With Unresectable Esophageal Squamous Cell Carcinoma
NCT06410651· 2. fázis· Cancer Institute and Hospital, Chinese Academy of Medical Sciences· Forrás
Contact: Xin Wang, doctor
Toboroz
Nimotuzumab Concurrent With Chemoradiotherapy for Esophageal Cancer Patients
NCT06429839· 2. fázis· Cancer Institute and Hospital, Chinese Academy of Medical Sciences· Forrás
Contact: Xin Wang, Doctor
Toboroz
A Prospective Study of Preoperative Tumor-bed Boost Followed by Oncoplastic Surgery and Adjuvant Whole Breast Radiotherapy for Early Stage Breast Cancer (BIRKIN)
NCT05603078· Cancer Institute and Hospital, Chinese Academy of Medical Sciences· Forrás
Contact: Hao Jing, M.D.
Még nem toboroz
Inetetamab Plus Rapamycin and Chemotherapy for HER2+ Metastatic Breast Cancer With Abnormal Activation of PAM Pathway
NCT04736589· 3. fázis· Peking Union Medical College· Forrás
Contact: Fei Ma, MD
Toboroz
Characteristics, Treatment Patterns and Outcomes for Patients With Surgically Resected Lung Cancers
NCT06255197· Cancer Institute and Hospital, Chinese Academy of Medical Sciences· Forrás
Contact: Fengwei Tan, MD